TickerSutra

NSE: DHANUKA · BSE: 507717 · ISIN INE435G01025

Dhanuka Agritech Limited stock analysis

Dhanuka Agritech Limited ranks #1281 in the TickerSutra evidence-ranked universe with a score of 55/100 and 95% data confidence. The latest captured fundamentals show ROCE of 23.8%, quarterly sales growth of -12.6% and quarterly profit growth of -34.6%.
Complete evidence gate pass governance reviewUpdated 29 Sept 2026
TICKERSUTRA SCORE55/100

Monitor only

#1281 of 5,430 ranked equities
Market capitalisation₹4,452.22cr
ROCE23.8%
Quarterly sales growth-12.6%
Quarterly profit growth-34.6%
P/E ratio16.6×
Promoter pledge0.0%

INVESTMENT EVIDENCE

What supports—and challenges—the thesis

Evidence in favour

  • ROCE is 23.8%
  • Low debt/equity of 0.02×
  • CWIP indicates an active capacity pipeline
  • No promoter shares are reported as pledged

Risks and constraints

  • CFO/EBITDA is below 0.6×

Still unresolved: Related-party exposure · Broad media sentiment

FINANCIAL TRAJECTORY

Recent operating history

PeriodRevenueOperating profitNet profitOperating margin
2022₹1,478cr₹264cr₹209cr18.0%
2023₹1,700cr₹279cr₹234cr16.0%
2024₹1,759cr₹327cr₹239cr19.0%
2025₹2,035cr₹417cr₹297cr20.0%
2026₹2,020cr₹404cr₹287cr20.0%
TTM₹1,953cr₹375cr₹268cr19.0%
Debt / equity0.02×
CFO / EBITDA0.49×
Operating margin19.0%
Free cash flow₹169cr
Sales CAGR · 3Y5.9%
Profit CAGR · 3Y7.0%

EXCHANGE EVENT TRIGGERS

Latest corporate disclosures

2 positive catalysts0 negative catalysts1 routine filings
RoutineTrading WindowNSE · 25 Sept 2026

Dhanuka Agritech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Positive CatalystProduct launch (Sub-para 3-Para B)NSE · 25 Sept 2026 · Structured filing

DHANUKA AGRITECH LIMITED has informed the Exchange about Product launch (Sub-para 3-Para B)

Readable disclosure summary

DHANUKA AGRITECH LIMITED has informed the Exchange about Product launch (Sub-para 3-Para B)

Open original XBRL source
Positive CatalystDhanuka Agritech Ltd - 507717 - Intimation Regarding Product LaunchNSE · 23 Sept 2026

Intimation regarding Product Launch

MANAGEMENT COMMENTARY

Signals from filed documents

Niche productsHigh severity · 1 mention
Positive catalyst

As you are aware, Dhanuka Agritech is among India's leading Agrochemical companies with a long-standing commitment towards advancing Indian agriculture through technology -led crop solutions. Over the years, we have built a strong pan -India franchise with deep farmer engagement and a differentiated product portfolio and a robust distribution network. Today we reach more than 10 million farmers across India through a

Pricing pressureHigh severity · 1 mention
Risk easing

Product category-wise Share was Insecticides contributed 25%, Fungicides contributed 14%, Herbicides contributed 42%, and others contributed 19%. While the 1st Quarter was impacted by delayed seasonal demand, pricing pressures, and external uncertainties, we believe these are largely cyclical challenges. The long-term growth drivers of Dhanuka Agritech Limited August 03, 2026 Page 4 of 17 the Indian Agrochemical indu

Product approvalsModerate severity · 2 mentions
Execution risk

continue to provide us access to the advanced technologies in differentiated solutions for Indian farmers. Our two R&D centers, supported by NABL accredited laboratories and a strong regulatory and product development team, remain focused on product registration, formulation development, and strengthening our future growth pipeline. The Agrochemical industry witnessed a significantly challenging 1st Quarter of FY 202

Regulatory updatesModerate severity · 2 mentions
Caution

continue to provide us access to the advanced technologies in differentiated solutions for Indian farmers. Our two R&D centers, supported by NABL accredited laboratories and a strong regulatory and product development team, remain focused on product registration, formulation development, and strengthening our future growth pipeline. The Agrochemical industry witnessed a significantly challenging 1st Quarter of FY 202

Margin expansionLow severity · 1 mention
Positive catalyst

Still in your books, it is showing that the price growth of over 12%. So, just wanted to understand if the price growth of over 12%, then why we have not got the benefit in terms of the low-cost inventory and vis -à-vis the gross margin improvement. That's the point I want to understand.

Export market updatesLow severity · 2 mentions
Constructive

We are sure we will win the case, absolutely. One was, are we looking to sign more deals in the international market like we did with Bayer and will it also help feed our Dahej plant capacity? As you are aware, Dhanuka is a debt-free company.

Pricing commentaryLow severity · 2 mentions
Caution

In addition, the sector continued to face challenges arising from elevated raw material and logistics costs during the quarter. Several companies attempted price increases during the initial months of the season to offset higher costs linked to geopolitical tensions in West Asia. However, weak market demand limited the sustainability of such hikes.

Regulatory approvalLow severity · 1 mention
Watch

Probably by August end, we will be launching the third one also. We have already received all the regulatory approvals and most of the stat es we have received the sale permission also. So, we will be going ahead with that.

Raw material inflationLow severity · 1 mention
Watch

Dhanuka Agritech Limited August 03, 2026 Page 11 of 17 Riju Dalui: No, sir. My question was that the price growth that we have seen in this quarter, so that was driven by the price hike, and that is led by the input cost inflation. Bansal: Price hike happened in the month of June.

Capacity expansion plansLow severity · 1 mention
Watch

Secondly, how should one think about the CAPEX numbers for ‘27, ‘28 and ‘29? Rahul Dhanuka: CAPEX plan for 2027, 2028 is-- Moderator: Hello, sir. Bansal: You see, in terms of this Nagpur, the CAPEX would be around Rs.

HOW TO READ THIS PAGE

Evidence, freshness and limitations

What does the TickerSutra score mean?

The score ranks captured evidence across financial quality, growth, moat and margins, regulatory catalysts, governance, institutional trend and valuation comfort. It is a research-prioritization tool—not a buy recommendation or price target.

Which sources support this page?

Financial history, ownership and pledge data, NSE and BSE filings, annual reports and available earnings-call transcripts are combined here. Use the source trail and original exchange document before relying on a decision-critical fact.

Why can an item be unresolved?

Unresolved means the current captured source window did not provide enough evidence for that check. It does not establish that a risk or relationship is absent.

Maintained by TickerSutra Research · Snapshot updated 29 Sept 2026 · Read the methodology · Read the disclaimer

DIRECTOR & BUSINESS NETWORK

Loading corporate intelligence

Loading universe coverage and exchange-backed evidence…